Lacosamide as the first add-on therapy in adult patients with focal epilepsy: A multicenter real-world study

BACKGROUND: Prospective observations on the effectiveness, safety, tolerance, and influence of comorbidity of add-on lacosamide (LCM) therapy are still lacking, especially for domestic generic LCM in China. OBJECTIVE: In this multicenter real-world study, we aimed to evaluate lacosamide (LCM) as the...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Wenyu, Li, Wenjing, Wang, Peiyu, Zhang, Hesheng, Zhang, Enhui, Wu, Xintong, Zhou, Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10117536/
https://www.ncbi.nlm.nih.gov/pubmed/37090978
http://dx.doi.org/10.3389/fneur.2023.1136814

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10117536/
https://www.ncbi.nlm.nih.gov/pubmed/37090978
http://dx.doi.org/10.3389/fneur.2023.1136814

Ejemplares similares